Neurocrine Biosciences to Present at Bear Stearns 15th Annual Healthcare Conference
SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at Bear Stearns 15th Annual Healthcare Conference held in New York on Tuesday, September 17, 2002 at 11:30AM Eastern Daylight Time (8:30AM Pacific Daylight Time). The presentation will be simultaneously webcast and can be viewed through a link provided via the Company's website at http://www.neurocrine.com
Gary Lyons, President and CEO of Neurocrine will discuss the Company's insomnia program as well as highlighting the Company's pipeline. Viewers are encouraged to visit the website approximately 15 minutes prior to the presentation to download or install any necessary audio software. If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. The presentation will be archived for 14 days.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.
Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X67437295
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Paul Hawran of Neurocrine Biosciences, +1-858-658-7600